Status:
UNKNOWN
Association Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active Conditions
Lead Sponsor:
Prof. Dr. Dr. Thomas Hilberg
Collaborating Sponsors:
Takeda
University of Bonn
Conditions:
Hemophilia A
Eligibility:
All Genders
12+ years
Brief Summary
The aim of this prospective multicentre study is to evaluate the influence of individual clotting factor level while being physically active
Detailed Description
In patients with haemophilia (PwH) repetitive joint bleedings result in a so called haemophilic arthropathy, which is often associated with chronic pain as well as functional restrictions. Due to the...
Eligibility Criteria
Inclusion
- patients suffering from moderate or severe hemophilia A (FVIII \<5%, ≥ 12 years old)
- factor treatment with ADVATE© or ADYNOVI©
- use of myPKFiT
Exclusion
- patients suffering from other coagulopathies
- participants without written consent
- participants \< 12 years old
- joint surgery like arthroscopy, synovectomy up to six months before study
- suffering from different rheumatologic diseases like M. Bechterew, Psoriasi or other local or generalized joint infections (Borreliosis, septic arthritis)
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04845555
Start Date
September 1 2019
End Date
December 30 2022
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Sports Medicine, University of Wuppertal
Wuppertal, North Rhine-Westphalia, Germany, 42117